| Literature DB >> 12942407 |
Jintanat Ananworanich1, Nittaya Phanuphak, Reto Nuesch, Wichitra Apateerapong, Ponlapat Rojnuckarin, Sasiwimol Ubolyam, Praphan Phanuphak, Kiat Ruxrungtham.
Abstract
In a structured treatment interruption (STI) trial, 3 of 23 patients in a CD4 cell count-guided treatment arm developed recurring thrombocytopenia associated with the interruption of antiretroviral therapy. All 3 patients had slightly low or normal platelet counts before initiating antiretroviral therapy. STI may play a role in inducing thrombocytopenia in patients with human immunodeficiency virus infection.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12942407 DOI: 10.1086/376989
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079